Indraprastha Medical Corporation Limited
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and… Read more
Indraprastha Medical Corporation Limited (INDRAMEDCO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.142x
Based on the latest financial reports, Indraprastha Medical Corporation Limited (INDRAMEDCO) has a cash flow conversion efficiency ratio of 0.142x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹935.10 Million) by net assets (₹6.58 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Indraprastha Medical Corporation Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Indraprastha Medical Corporation Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Indraprastha Medical Corporation Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Indraprastha Medical Corporation Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hanssem
KO:009240
|
0.096x |
|
Volue AS
OL:VOLUE
|
-0.091x |
|
Virginia National Bankshares Corp
NASDAQ:VABK
|
0.032x |
|
Minami Acoustics Ltd. A
SHE:301383
|
N/A |
|
Chemplast Sanmar Limited
NSE:CHEMPLASTS
|
0.039x |
|
Selvas Ai Inc.
KQ:108860
|
-0.006x |
|
Tianjin Motimo Membrane Tech
SHE:300334
|
-0.028x |
|
SANIONA AB (PUBL)
F:30S
|
N/A |
Annual Cash Flow Conversion Efficiency for Indraprastha Medical Corporation Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Indraprastha Medical Corporation Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹5.97 Billion | ₹1.57 Billion | 0.263x | -37.29% |
| 2024-03-31 | ₹4.78 Billion | ₹2.00 Billion | 0.419x | +10.03% |
| 2023-03-31 | ₹3.79 Billion | ₹1.44 Billion | 0.381x | +73.81% |
| 2022-03-31 | ₹3.25 Billion | ₹712.90 Million | 0.219x | +114.17% |
| 2021-03-31 | ₹2.73 Billion | ₹278.98 Million | 0.102x | -68.32% |
| 2020-03-31 | ₹2.68 Billion | ₹864.51 Million | 0.323x | +4.78% |
| 2019-03-31 | ₹2.44 Billion | ₹751.85 Million | 0.308x | +50.05% |
| 2018-03-31 | ₹2.32 Billion | ₹477.00 Million | 0.205x | +66.93% |
| 2017-03-31 | ₹2.31 Billion | ₹283.93 Million | 0.123x | -59.68% |
| 2016-03-31 | ₹2.03 Billion | ₹619.73 Million | 0.305x | -7.59% |
| 2015-03-31 | ₹1.95 Billion | ₹643.01 Million | 0.330x | +6.32% |
| 2014-03-31 | ₹1.87 Billion | ₹581.04 Million | 0.311x | -20.57% |
| 2013-03-31 | ₹1.71 Billion | ₹668.48 Million | 0.391x | +12.26% |
| 2012-03-31 | ₹1.59 Billion | ₹554.69 Million | 0.348x | +43.00% |
| 2011-03-31 | ₹1.49 Billion | ₹363.66 Million | 0.244x | -54.73% |
| 2010-03-31 | ₹1.36 Billion | ₹730.06 Million | 0.538x | +9.49% |
| 2009-03-31 | ₹1.22 Billion | ₹598.51 Million | 0.491x | +2.43% |
| 2008-03-31 | ₹1.14 Billion | ₹546.89 Million | 0.480x | +169.65% |
| 2007-03-31 | ₹1.13 Billion | ₹201.81 Million | 0.178x | -21.75% |
| 2006-03-31 | ₹1.12 Billion | ₹254.91 Million | 0.227x | -- |